Establishment Labs (NASDAQ:ESTA) Trading 7.9% Higher – Here’s What Happened

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) were up 7.9% during trading on Tuesday . The company traded as high as $45.72 and last traded at $46.28. Approximately 601,434 shares traded hands during trading, an increase of 46% from the average daily volume of 411,352 shares. The stock had previously closed at $42.88.

Analysts Set New Price Targets

Separately, Stephens reissued an “overweight” rating and issued a $52.00 price objective on shares of Establishment Labs in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $57.40.

Establishment Labs Trading Up 7.7 %

The stock has a market capitalization of $1.29 billion, a P/E ratio of -17.91 and a beta of 1.12. The stock’s fifty day moving average price is $37.52 and its 200 day moving average price is $41.34. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). The company had revenue of $44.51 million for the quarter, compared to analysts’ expectations of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. Research analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Institutional Investors Weigh In On Establishment Labs

Hedge funds have recently made changes to their positions in the company. Quarry LP bought a new stake in shares of Establishment Labs in the fourth quarter valued at about $27,000. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Establishment Labs by 1.8% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company’s stock valued at $1,525,000 after purchasing an additional 632 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Establishment Labs in the 4th quarter worth approximately $36,000. Federated Hermes Inc. increased its holdings in Establishment Labs by 3.0% during the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company’s stock valued at $1,507,000 after buying an additional 953 shares during the period. Finally, Swiss National Bank raised its stake in Establishment Labs by 2.7% in the fourth quarter. Swiss National Bank now owns 38,500 shares of the company’s stock worth $1,774,000 after buying an additional 1,000 shares in the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.